Clinical Trials Logo

Pregnancy, Ovarian clinical trials

View clinical trials related to Pregnancy, Ovarian.

Filter by:
  • None
  • Page 1

NCT ID: NCT03693534 Recruiting - Pregnancy, Ovarian Clinical Trials

Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Long Agonist Protocol

Start date: February 15, 2017
Phase:
Study type: Observational

A prospective study of the evaluation of the clinical IVF (in vitro fertilization) results after following Long Antagonist protocol for Controlled Ovarian Stimulation (COS) versus following Long Agonist protocol

NCT ID: NCT03684421 Recruiting - Pregnancy, Ovarian Clinical Trials

Clinical and Live Birth Rates After Following Long Antagonist Protocol Versus Classical Antagonist Protocol

Start date: February 15, 2017
Phase:
Study type: Observational

A randomized prospective study of the evaluation of the clinical IVF results after following Long Antagonist protocol for controlled ovarian stimulation versus following classical antagonist protocol

NCT ID: NCT03463278 Recruiting - Pregnancy, Ovarian Clinical Trials

The Number of Blastocysts Formed in the Outcome of Freeze All Strategy: COMFFETI Trial, Cumulative Delivery Rate

Start date: November 1, 2013
Phase:
Study type: Observational

A prospective study of the blastulation rate in the outcome of the Freeze all strategy

NCT ID: NCT03240159 Recruiting - Pregnancy, Ovarian Clinical Trials

Long Antagonist Protocol for IVF With Single Luteal Dose of Degarelix

Start date: February 15, 2017
Phase: Phase 3
Study type: Interventional

A prospective study of three different doses of Degarelix in late luteal phase of women undergoing ovarian stimulation for IVF

NCT ID: NCT02442895 Completed - Pregnancy, Ovarian Clinical Trials

Biomarkers of Ovarian Reserve and Correlation With IVF Treatments

Start date: February 2014
Phase: N/A
Study type: Observational

Retrospective study to evaluate the correlation between AFC, FSHb, AMH and IVF outcomes of 347 cycles performed with three different protocols.

NCT ID: NCT00773825 Completed - Pregnancy, Ovarian Clinical Trials

Genomic Imprinting and Assisted Reproductive Technologies

EPIGEN
Start date: February 2007
Phase: N/A
Study type: Observational

Genomic imprinting, referring to an epigenetic marking resulting in monoallelic gene expression, plays a critical role in development. Recently, various imprinting diseases were reported in animals (Large Offspring syndrome (LOS)) and humans (Beckwith-Wiedemann syndrome (BWS) and Angelman syndrome (AS)) born after ART. In all cases, an imprinting defect was involved (loss of methylation at ICR2 in BWS, at SNRPN in AS and at IGF2R DMR2 in LOS). These data suggest that ART procedures may impair the establishment or the maintenance (following fertilization) of methylation marks at maternally imprinted loci. In view of these data, the aim of this study is to determine if children born following ART exhibit an increased risk of imprinting defects. If the answer is yes, the second objective is to identify the problematic step in the ART procedure and thus to suppress or modify this step.